Medical News

RSS

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®. People living with hemophilia face many daily challenges, and Novo Nordisk is committed to helping this community realize that there is also a lifetime of possibilities.

From Novo Nordisk 31 Oct 2009

New diagnostic test for detecting colorectal cancer

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

31 Oct 2009

Immunotherapy, a new therapeutic area to destroy tumor cells

Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

31 Oct 2009

Study: Gene therapy can reduce symptoms of Huntington's disease

Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

31 Oct 2009

Miami resident pleads guilty on conspiracy to defraud the Medicare program

Miami resident Daisy Martinez pleaded guilty today in U.S. District Court in Detroit to participating in a conspiracy to defraud the Medicare program, Assistant Attorney General Lanny A. Breuer of the Criminal Division; U.S. Attorney Terrence Berg of the Eastern District of Michigan; Andrew G. Arena, Special Agent-in-Charge of the Detroit Field Office of the FBI; and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS) announced.

31 Oct 2009

Accuray to focus on its CyberKnife Robotic Radiosurgery System at the ASTRO meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place November 1 - 5 in Chicago, Illinois. This represents a 27 percent increase in CyberKnife abstracts over last year's Annual Meeting.

31 Oct 2009

Initiate Systems announces Accenx Technologies acquisition; expands growth strategy in the healthcare market

Initiate Systems, Inc., a leader in data management solutions for information sharing and improved data quality, has acquired Accenx Technologies, Inc., a leading provider of health information exchange solutions. This acquisition furthers Initiate’s growth strategy and expands its offerings in the healthcare market. The terms of the deal are confidential.

31 Oct 2009

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest.

31 Oct 2009

Texas McAllen Hospitals violates the False Claims Act, to pay $27.5M for settling allegations

A hospital group based in McAllen, Texas, has agreed to pay the United States $27.5 million to settle claims that it violated the False Claims Act, the Anti-Kickback Statute and the Stark Statute between 1999 and 2006, by paying illegal compensation to doctors in order to induce them to refer patients to hospitals within the group, the Justice Department announced today.

31 Oct 2009

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

Data presented today from a 310 patient, 52 week, double-blind, controlled clinical trial demonstrates that a micronutrient supplement, Replenish+™ delays the progression of AIDS in HIV-infected patients not receiving antiretroviral treatment (ART).

31 Oct 2009

Revised standards for four ingredients widely used in prescription and over-the-counter drugs announced

To further protect patients from adulterated medicines, the U.S. Pharmacopeial Convention (USP) today announced revised standards for four ingredients widely used in prescription and over-the-counter drugs.

31 Oct 2009

AARP praises General Assembly for preserving critical health care program

Older adults increasingly feeling the pinch of the recession got a significant break from the Illinois General Assembly, as legislators overrode a partial veto from Gov. Quinn on Thursday, preserving a program aimed at helping Medicare beneficiaries afford prescription drugs.

31 Oct 2009

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.

31 Oct 2009

Geron plans to advance clinical program for spinal cord injury

Geron Corporation today announced the company’s plan to advance clinical development of its human embryonic stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury.

31 Oct 2009

MedImpact to provide a suite of free, online flu self-assessment tools

MedImpact has collaborated with the American Medical Association (AMA) and other health care organizations to provide a suite of free, online flu self-assessment tools to MedImpact clients and to the 32 million individual members they serve.

31 Oct 2009

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

The U.S. Food and Drug Administration today sent a warning letter to Procter & Gamble notifying the company that its Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C are illegally marketed combinations of drug ingredients and a dietary ingredient.

31 Oct 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Rural and small, suburban hospitals in North Carolina and Virginia can now provide a higher level of emergency stroke and critical neurology care, 24 hours a day, 365 days a year, as part of a new teleneurology medicine program announced Oct. 26, 2009, by Forsyth Medical Center (FMC).

31 Oct 2009

Male attraction operates differently from female attraction, regardless of sexual orientation

A new study from a researcher at Harvard University finds that gay men are most attracted to the most masculine-faced men, while straight men prefer the most feminine-faced women.

31 Oct 2009

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.

31 Oct 2009

Muslim civil rights organization says 'no hat' policy must have religious exemption

The Council on American-Islamic Relations (CAIR) today called on a major medical group in Texas to change its policy denying accommodation for Muslim employees who wear religious attire such as Islamic head scarves (hijab) or beards.

31 Oct 2009

Medical News

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

New diagnostic test for detecting colorectal cancer

Immunotherapy, a new therapeutic area to destroy tumor cells

Study: Gene therapy can reduce symptoms of Huntington's disease

Miami resident pleads guilty on conspiracy to defraud the Medicare program

Accuray to focus on its CyberKnife Robotic Radiosurgery System at the ASTRO meeting

Initiate Systems announces Accenx Technologies acquisition; expands growth strategy in the healthcare market

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

Texas McAllen Hospitals violates the False Claims Act, to pay $27.5M for settling allegations

Replenish+ delays the progression of AIDS in HIV-infected patients not receiving ART

Revised standards for four ingredients widely used in prescription and over-the-counter drugs announced

AARP praises General Assembly for preserving critical health care program

NovaBay Pharmaceuticals' Aganocide compounds demonstrate potent antifungal activity against onychomycosis

Geron plans to advance clinical program for spinal cord injury

MedImpact to provide a suite of free, online flu self-assessment tools

Procter & Gamble's Vicks products containing vitamin C being marketed unlawfully, FDA warns

New teleneurology medicine program to provide 24-hour emergency services launched

Male attraction operates differently from female attraction, regardless of sexual orientation

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

Muslim civil rights organization says 'no hat' policy must have religious exemption

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News